Literature DB >> 30301574

Direct Anterior Approach and Perioperative Fracture With a Single-Taper Wedge Femoral Component.

Nicholas J Greco1, Adolph V Lombardi2, Michael J Morris1, Gerald R Hobbs3, Keith R Berend1.   

Abstract

BACKGROUND: Despite growing interest in direct anterior approach total hip arthroplasty, perioperative femoral fracture and early aseptic loosening are increasingly recognized complications. Previous research has documented the role of surgeon experience in association with these femoral complications. The purpose of this study was to explore the relationship between femoral component design and early periprosthetic femoral complications.
METHODS: This was an extension of previous work with an updated patient cohort of 5090 consecutive direct anterior primary total hip arthroplasties at a single institution with a single-taper, wedge femoral stem comprising 4 variants involving length and geometry: group 1, full-length, standard profile; group 2, full-length, reduced distal profile; group 3, short-length, standard profile; and group 4, short-length, reduced distal profile. Records were reviewed retrospectively for the incidence of early postoperative periprosthetic fracture or aseptic loosening and analyzed with regard to patient demographics and femoral stem type.
RESULTS: There were 42 (0.83%) periprosthetic femur complications observed in the early postoperative period. Increased age (P < .001) and female gender (P = .023) were significantly associated with incidence of femoral complications in univariate analysis, while age maintained this significant relationship in multivariate analysis (P < .001). There was a trend toward increased complication rate in patients receiving a short stem with full profile taper (1.27%, P = .0539).
CONCLUSION: Despite an overall low rate of femoral complications after direct anterior total hip arthroplasty, the risk is increased in elderly patients and females. Furthermore, femoral stem design may portend an elevated risk of these complications.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aseptic loosening; direct anterior approach; femoral periprosthetic fracture; femoral stem; total hip arthroplasty

Mesh:

Year:  2018        PMID: 30301574     DOI: 10.1016/j.arth.2018.09.003

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  6 in total

1.  Risk Factors for Periprosthetic Femoral Fracture in Non-cemented Total Hip Arthroplasty Through the Direct Anterior Approach.

Authors:  Zachary Berliner; Cameron Yau; Kenneth Jahng; Marcel A Bas; H John Cooper; José A Rodriguez
Journal:  HSS J       Date:  2021-10-18

2.  Is the Direct Anterior Approach to THA Cost-effective? A Markov Analysis.

Authors:  Ari R Berg; Michael B Held; Boshen Jiao; Eric Swart; Akshay Lakra; H John Cooper; Roshan P Shah; Jeffrey A Geller
Journal:  Clin Orthop Relat Res       Date:  2022-03-04       Impact factor: 4.755

Review 3.  Periprosthetic joint infection rates across primary total hip arthroplasty surgical approaches: a systematic review and meta-analysis of 653,633 procedures.

Authors:  Alexander J Acuña; Michael T Do; Linsen T Samuel; Daniel Grits; Jesse E Otero; Atul F Kamath
Journal:  Arch Orthop Trauma Surg       Date:  2021-09-30       Impact factor: 2.928

4.  Direct anterior approach hip arthroplasty: How to reduce complications - A 10-years single center experience and literature review.

Authors:  Fabrizio Rivera; Luca C Comba; Alessandro Bardelli
Journal:  World J Orthop       Date:  2022-04-18

5.  Risk factors for femoral fracture in lateral decubitus direct anterior approach total hip arthroplasty using conventional stems: a retrospective analysis.

Authors:  Guanjun Sun; Yi Yin; Yongjie Ye; Qingshan Li
Journal:  J Orthop Surg Res       Date:  2021-01-30       Impact factor: 2.359

6.  Early low complication rate of ceramic-on-ceramic total hip arthroplasty by direct anterior approach.

Authors:  Paul Henri Bauwens; Camdon Fary; Elvire Servien; Sébastien Lustig; Cécile Batailler
Journal:  SICOT J       Date:  2020-08-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.